Ken-ichi Hanada, M.D., Ph.D.

Team Member of:
Dr. Hanada received M.D. degree at Tokyo Medical and Dental University and a Ph.D. at the University of Tokyo, Japan. He joined the Surgery Branch, NCI in 1997 as a visiting scientist and became a staff scientist in 2005. He has been involved in the basic studies of immune response to renal cell carcinoma and also in the development of clinical trials for renal cell carcinoma.
renal cell carcinoma
Contact Info
Center for Cancer Research
National Cancer Institute
Building 10, Room 3w-3840
Bethesda, MD 20892-1201
Ph: 240-858-3774
hanadak@mail.nih.gov
Selected Publications
- J. Clin. Invest.. [Epub ahead of print], 2014. [ Journal Article ]
- Nat. Biotechnol.. 31: 33-4, 2013. [ Journal Article ]
- Blood. 122: 1399-410, 2013. [ Journal Article ]
- Immunity. 36: 79-91, 2012. [ Journal Article ]
- Cancer Res.. 72: 6119-29, 2012. [ Journal Article ]
Dr. Hanada received M.D. degree at Tokyo Medical and Dental University and a Ph.D. at the University of Tokyo, Japan. He joined the Surgery Branch, NCI in 1997 as a visiting scientist and became a staff scientist in 2005. He has been involved in the basic studies of immune response to renal cell carcinoma and also in the development of clinical trials for renal cell carcinoma.